New Launch7 Aug 2025, 04:41 pm
Zydus Lifesciences Receives NOC from Health Canada for ZDS-Varenicline Tablets
AI Summary
Zydus Lifesciences Limited has received a Notice of Compliance (NOC) from Health Canada for ZDS-Varenicline tablets 0.5 & 1 mg. This is the group's first NOC approval in Canada. The tablets will be produced at Zydus Lifescience Ltd, SEZ, Ahmedabad. Varenicline is used as an aid in smoking cessation and had annual sales of 15 mn Canadian dollar in Canada (IQVIA MAT December 2024).
Key Highlights
- Zydus Lifesciences receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
- This is the group's first NOC approval in Canada
- Varenicline is used as an aid in smoking cessation
- ZDS-Varenicline tablets will be produced at Zydus Lifescience Ltd, SEZ, Ahmedabad
- Varenicline tablets had annual sales of 15 mn Canadian dollar in Canada (IQVIA MAT December 2024)